A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases

NCT05742217 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer